About us
LTU School of Cancer Medicine
Our Partners
Our People
Our Corporate Publications
Our Policies
A message from our Founding Champion
Our Research
Research Programs
Genome Engineering and Cancer Modelling Program
Blood Cancer and Immunotherapy Laboratory
Tumour Environment and Immunology Program
Cancer and Inflammation Laboratory
Tumour Immunology Laboratory
Mucosal Immunity and Cancer Laboratory
Tissue and Tumour Immunity Laboratory
Tumour Microenvironment and Cancer Signaling Group
Cytokine and Cancer Signalling Group
Cancer Biology and Therapy Program
Oncogenic Transcription Laboratory
Metastasis Research Laboratory
Tumour Progression and Heterogeneity Laboratory
Cell Death and Survival Laboratory
Cancer Single Cell Genomics Laboratory
Molecular Immunology Laboratory
Tumour Targeting Program
Tumour Targeting Laboratory
Receptor Biology Laboratory
Centre for Research Excellence in Brain Cancer
Bioinformatics and Cancer Genomics Laboratory
Research Platforms
The ACRF Centre for Translational Cancer Therapeutics and Imaging
The ACRF Centre for Imaging the Tumour Environment
VECTRA Multi-Spectral Imaging Platform
Mammalian Protein Expression Facility
Flow Cytometry Core Facility
Clinical Trials
Latest news
Join our team
Study opportunities
Career opportunities
Volunteer Opportunities
Contact us
Support us
Donate now
Search
Research
Science Meets Art Exhibition
Read More
World-first research breakthrough sparks new hope for bowel cancer patients
Read More
Let sleeping cells die: Understanding dormant breast cancer cells
Read More
World-class Radiochemistry Lab to open at Olivia Newton-John Cancer Research Institute – giving Australian cancer patients access to new therapies
Read More
Breakthrough research results give hope to pancreatic cancer patients
Read More
Rare Cancer Trial Extended Nationwide
Read More
Learning from low response rates
Read More
Rare cancer models: the key to improving biliary cancer outcomes
Read More
A new pathway for colon cancer progression
Read More
Professor Andrew Scott awarded national grant to target Triple-Negative Breast Cancers
Read More
Privacy Preference Center
Privacy Preferences
